Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Barbara L. Sommers"'
Autor:
William Lyons, Marshall Flam, Steven Hager, Jonathan B. Blitzer, Robert A. Nagourney, Barbara L. Sommers, Steven S. Evans, John S. Link
Publikováno v:
Clinical Breast Cancer. 8:432-435
Purpose The combination of cisplatin plus gemcitabine is active in metastatic breast cancer. Carboplatin plus gemcitabine, widely used in ovarian and non–small-cell lung cancers, has also been used in breast cancer. This trial examined the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a32b78710d065f1e1ca553d1121097
https://doi.org/10.3816/cbc.2008.n.052
https://doi.org/10.3816/cbc.2008.n.052
Publikováno v:
British Journal of Cancer
Topotecan is currently approved for relapsed small-cell lung cancer and ovarian cancer. Topotecan's efficacy in the second-line setting and novel mechanism of action suggest broad antitumour activity. We utilised a clinically validated, cell-death, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f87e0e55016186cea9a4453f6c1160
https://doi.org/10.1038/sj.bjc.6601336
https://doi.org/10.1038/sj.bjc.6601336
Autor:
Barbara L. Sommers, Wesley A. Kidder, David R. Minor, Philip J. DiSaia, Robert A. Nagourney, Cheryl A. Brewer, Steven S. Evans, Stephen E. Radecki
Publikováno v:
Gynecologic Oncology. 88:35-39
Objectives. The aim was to determine the safety and efficacy of gemcitabine plus cisplatin for patients with relapsed ovarian carcinoma and to compare ex vivo drug sensitivity profiles with clinical outcomes. Patients and methods. Previously treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::947ea561de28e8bf31d9dce97169cd79
https://doi.org/10.1006/gyno.2002.6855
https://doi.org/10.1006/gyno.2002.6855